Clinical trial
Treatment Targets for Chronic Hypertension in Pregnancy
NCT00194974 · Weill Medical College of Cornell University, Other · Withdrawn
Key facts
| NCT number | NCT00194974 |
|---|---|
| Title | Treatment Targets for Chronic Hypertension in Pregnancy |
| Official title | Treatment Targets for Chronic Hypertension in Pregnancy |
| Lead sponsor | Weill Medical College of Cornell University, Other |
| Status | Withdrawn |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Pregnancy Toxemia, Hypertension, Proteinuria |
| Intervention type | Drug |
| Interventions | methyldopa, labetalol, nifedipine, clonidine |
| Enrollment | 0 |
| Start date | Jul 1, 2004 |
| Primary completion | Mar 1, 2005 |
| Completion | Mar 1, 2005 |
| First posted | Sep 19, 2005 |
| Last update posted | Jan 30, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: